Posted inLondon Stock Exchange
Venture Life acquires FemiClear & CUROXEN for up to $28 million
LONDON: Venture Life (AIM: VLG), a recognised leader in proactive longevity, health innovation and global commercialisation within the consumer healthcare sector, announced the acquisition of FemiClear, and CUROXEN (together with FemiClear, the "Brands"), from OrganiCare Nature's…











